Skip to content

Merck to seek emergency authorization for oral Covid treatment after ‘compelling results’ in trials – CNBC

Merck to seek emergency authorization for oral Covid treatment after ‘compelling results’ in trials  CNBCMerck says experimental pill cuts worst effects of COVID-19  Associated PressMolnupiravir, a drug developed by Merck, could be the first oral antiviral medicine for covid-19  The Washington PostCovid News: Live Updates  The New York TimesMerck CEO: Antiviral pill could make Covid manageable  CNBC TelevisionView Full Coverage on Google News

Leave a Reply

Your email address will not be published. Required fields are marked *